These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21920188)

  • 1. Current issues and available options in combined hormonal contraception.
    Bitzer J; Simon JA
    Contraception; 2011 Oct; 84(4):342-56. PubMed ID: 21920188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current challenges in contraception in adolescents and young women.
    Cornet A
    Curr Opin Obstet Gynecol; 2013 Mar; 25 Suppl 1():S1-10. PubMed ID: 23370330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined hormonal contraception.
    Calderoni ME; Coupey SM
    Adolesc Med Clin; 2005 Oct; 16(3):517-37. PubMed ID: 16183537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives.
    Shulman LP
    Am J Obstet Gynecol; 2011 Oct; 205(4 Suppl):S9-13. PubMed ID: 21961825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal contraception.
    Baird DT; Glasier AF
    N Engl J Med; 1993 May; 328(21):1543-9. PubMed ID: 8479492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in hormonal contraception.
    Erkkola R
    Curr Opin Obstet Gynecol; 2007 Dec; 19(6):547-53. PubMed ID: 18007132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethinylestradiol + norelgestromin: new preparation. Transdermal contraception: no tangible progress.
    Prescrire Int; 2004 Aug; 13(72):123-6. PubMed ID: 15532134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advances in hormonal contraception].
    Villanueva Egan LA; Pichardo Cuevas M
    Ginecol Obstet Mex; 2007 Jan; 75(1):35-42. PubMed ID: 17542267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal contraceptive methodology: an historical review.
    Linn ES
    Int J Fertil Womens Med; 2005; 50(2):88-96. PubMed ID: 16334417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosexual well-being in women using oral contraceptives containing drospirenone.
    Nappi RE; Albani F; Tonani S; Santamaria V; Pisani C; Terreno E; Martini E; Polatti F
    Funct Neurol; 2009; 24(2):71-5. PubMed ID: 19775533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oral contraception: failures and risks].
    Foussard-blanpin O; Paillot-renaud P; Bruneau-bigot A
    Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing patient telephone callback rates for different hormonal birth control delivery systems.
    Victor I; Fink RA
    Am J Ther; 2006; 13(6):507-12. PubMed ID: 17122531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoting the safety and use of hormonal contraceptives.
    Gardner J; Miller L
    J Womens Health (Larchmt); 2005; 14(1):53-60. PubMed ID: 15692278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current perspectives on combination oral contraceptives.
    Smith MA; Youngkin EQ
    Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future developments in hormonal contraception.
    Johansson ED
    Am J Obstet Gynecol; 2004 Apr; 190(4 Suppl):S69-71. PubMed ID: 15105801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended cycle combined hormonal contraception.
    Steinauer J; Autry AM
    Obstet Gynecol Clin North Am; 2007 Mar; 34(1):43-55, viii. PubMed ID: 17472864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale for new oral contraceptive dosing.
    Williams JK
    Int J Fertil Womens Med; 2004; 49(1):30-5. PubMed ID: 15038507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH).
    Sacco S; Merki-Feld GS; Ægidius KL; Bitzer J; Canonico M; Gantenbein AR; Kurth T; Lampl C; Lidegaard Ø; Anne MacGregor E; MaassenVanDenBrink A; Mitsikostas DD; Nappi RE; Ntaios G; Paemeleire K; Sandset PM; Terwindt GM; Vetvik KG; Martelletti P;
    J Headache Pain; 2018 Aug; 19(1):76. PubMed ID: 30171365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.